MyFinsight
Home
Blog
About
Cash and cash
equivalents
$2,429,719
(202.64%↑ Y/Y)
Accounts and other
receivables, net
$894,823
(112.11%↑ Y/Y)
Prepaid expenses and
other current assets
$458,360
(14.55%↑ Y/Y)
Inventory
$82,378
(87.35%↑ Y/Y)
Cost
$850,000
Property and equipment,
gross
$1,016,992
(4.22%↑ Y/Y)
Total current assets
$3,865,280
(131.62%↑ Y/Y)
Goodwill
$1,404,486
(0.00%↑ Y/Y)
Operating lease
right-of-use asset, net
$769,270
(92.38%↑ Y/Y)
Intangible assets, net
$687,639
(-7.82%↓ Y/Y)
Finance lease
right-of-use asset, net
$562,187
(235.17%↑ Y/Y)
Property and equipment,
net
$313,708
(-10.72%↓ Y/Y)
Other assets
$16,709
(30.40%↑ Y/Y)
Accumulated amortization
$162,361
Less accumulated
depreciation and...
$703,284
(12.62%↑ Y/Y)
Total assets
$7,619,279
(60.37%↑ Y/Y)
Customer Relationships
$139,167
Trademarks And Trade Names
$23,194
Total liabilities and
stockholders equity
$7,619,279
(60.37%↑ Y/Y)
Total liabilities
$3,850,482
(-44.09%↓ Y/Y)
Total stockholders
equity
$3,768,797
(276.43%↑ Y/Y)
Accumulated deficit
-$75,550,756
(-25.16%↓ Y/Y)
Total current
liabilities
$2,680,906
(3.58%↑ Y/Y)
Operating lease
liability, net of current...
$637,643
(132.65%↑ Y/Y)
Finance lease
liability, net of current...
$495,468
(12468.95%↑ Y/Y)
Notes payable, net of
current portion
$36,465
(-20.65%↓ Y/Y)
Additional paid-in capital
$79,272,098
(36.60%↑ Y/Y)
Common stock, par value
0.007 per share...
$47,454
(-75.94%↓ Y/Y)
Preferred stock, par value
0.001 per share...
$1
Accrued expenses
$1,414,492
(34.97%↑ Y/Y)
Accounts payable
$969,845
(-17.10%↓ Y/Y)
Operating lease
liability, current portion
$163,276
(22.54%↑ Y/Y)
Finance lease
liability, current portion
$79,592
(-55.74%↓ Y/Y)
Unearned revenue
$31,140
(27.60%↑ Y/Y)
Notes payable,
current portion
$22,561
(-31.52%↓ Y/Y)
Back
Back
Balance Sheet
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF)
source: myfinsight.com